SUSANA VIERA: Open Payments
NPI 1073763082 · DARTMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$426 in 8 payments from 4 companies in 2025. Trend: 2023 $613 · 2024 $510 · 2025 $426
Food & beverage: $426
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $188 |
| Neurocrine BioSciences, Inc. | 2 | $144 |
| Baxter Healthcare | 2 | $62 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $32 |
Products named: Ozempic, INGREZZA, PERCLOT, REXULTI, FLOSEAL, Rybelsus.
Industry payments across MA — which companies pay providers there.
